Back
GT Biopharma, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
20
GTBP
GT Biopharma, Inc.
Last Price:
$0.75
Seasonality Move:
-5.56%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atGT Biopharma, Inc. Stock Forecast
-
Is GT Biopharma, Inc. Stock Undervalued?The current GT Biopharma, Inc. [GTBP] share price is $0.75. The Score for GTBP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
GTBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will GT Biopharma, Inc. Stock Go Up Next Year?
Data Unavailable
GT Biopharma, Inc. Stock Rating
Data Unavailable
GT Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
gtbiopharma.com
52-Week Data
52-Week High:
3.85
52-Week Low:
0.54
Prediction Charts
Market Cap:
7.9M
Price in USD:
0.75
Volume:
2.1M
Beta:
0.95
Technical Analysis
SMA50:
0.71
SMA100:
0.75
SMA200:
1.55
52-Wk Change:
-67.99%
Stock Predictions
-
Is GT Biopharma, Inc. stock public?Yes, GT Biopharma, Inc. is a publicly traded company.
-
What is the GT Biopharma, Inc. stock quote today?The GT Biopharma, Inc. stock price is 0.75 USD today.
-
How to buy GT Biopharma, Inc. stock online?You can buy GT Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-26 | 0.87 | 0.83 | 0.87 | 0.78 |
| Dec-29 | 0.87 | 0.92 | 0.93 | 0.83 |
| Dec-30 | 0.94 | 0.81 | 0.94 | 0.80 |
| Dec-31 | 0.84 | 0.79 | 0.84 | 0.75 |
| Jan-5 | 0.86 | 0.80 | 0.86 | 0.76 |
| Jan-6 | 0.79 | 0.79 | 0.81 | 0.77 |
| Jan-7 | 0.80 | 0.73 | 0.80 | 0.72 |
| Jan-8 | 0.72 | 0.68 | 0.72 | 0.66 |
| Jan-9 | 0.67 | 0.68 | 0.69 | 0.61 |
| Jan-12 | 0.69 | 0.73 | 0.75 | 0.67 |
| Jan-13 | 0.73 | 0.69 | 0.73 | 0.67 |
| Jan-14 | 0.68 | 0.66 | 0.69 | 0.65 |
| Jan-15 | 0.75 | 0.73 | 0.75 | 0.70 |
| Jan-16 | 0.73 | 0.75 | 0.78 | 0.68 |
GT Biopharma, Inc. Earnings
Data Unavailable
GT Biopharma, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.93 per share, and a decrease next year of $0.00 per share.
* GT Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.